Protagonist Therapeutics Inc (PTGX)
$18.49
0.01 (0.05%)
PTGX Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
392.06M
PE Ratio
-11.48
EPS
-1.61
Volume (Avg. Vol.)
241,800
Day's Range
18.16 - 18.78
52-Week Range
4.47 - 23.25
Dividend & Yield
N/A (N/A)
PTGX Stock Predictions, Articles, and Protagonist Therapeutics Inc News
Protagonist Stock Jumps 58% After Re-Review of Test Results
A re-review of the PTG-100 results undid the bad news of a discontinuation of Protagonist's clinical study. If the FDA allows the company to run Phase 2/3 studies for PTG-100, then the stock will continue its bounce higher.
Western Refining, Inc. (WNR) Signet Jewelers Ltd. (SIG) Leads 16 Activist Investor Filings
13D and 13G filings are windows into activist investor activity. Today we focus on Western Digital and 15 other filings
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
